Companies Dominating the Genetic Testing Landscape
- Genentech Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sorenson Genomics
- Abbott Molecular
- Bayer AG
- Biocartis
- BioHelix
- Quest Diagnostics
- Exact Sciences Corporation
- HTG Molecular Diagnostics, Inc.
- PacBio
Browse Key Market Insights with Data Illustration:
In the News
- Quest Diagnostics, announced the acquisition of Blueprint Genetics in an all-cash equity deal. Using proprietary algorithms and next-generation sequencing (NGS), Blueprint Genetics is a top provider of specialized genetic testing. It has extensive experience interpreting gene variants. In order to improve patient care and pharmaceutical medication research and development, Quest and Blueprint Genetics was estimated to provide access to practical insights into genetic and uncommon diseases. The deal's financial specifics weren't made public.
- Exact Sciences Corporation declared that it had acquired PreventionGenetics, a genetic testing facility, in order to expand its portfolio of advanced cancer diagnostics and assist its entry into hereditary cancer testing (HCT). In order to speed up the availability of HCT and assisted more individuals in understanding their germline risk of developing cancer and other diseases, PreventionGenetics offers the clinical lab, experience, and fundamental technologies required.
